Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer

Citation

de Paula B, Cexus O, Townsend P & Crocamo S (2025) Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer. Asian Journal of Surgery, 48 (1), pp. 566-567. https://doi.org/10.1016/j.asjsur.2024.07.024

Abstract
First paragraph: Dear Editor, We recently came across Mei Liu et al meta-analysis, a comprehensive study published in 2023, and wish to discuss a few aspects.

Keywords
Her2-positive breast cancer; Zoledronic acid; Pathological complete response rate

Journal
Asian Journal of Surgery: Volume 48, Issue 1

• Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer